-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense Therapeutics FY EPS $(0.44) Misses $(0.35) Estimate

Benzinga·03/31/2026 13:28:36
Listen to the news
NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.35) by 25.71 percent.